GE to Keep Life-Science Unit Despite Shift to Heavy Industry

29906170001_4165095351001_video-still-for-video-4165086587001General Electric Co. plans to keep its $4 billion life-sciences operations even as the manufacturing giant remakes itself around heavy industry.

GE is looking to expand investment in the fast-growing business, Healthcare Chief Executive Officer John Flannery said Friday at an investor meeting. Sales in life sciences, which makes products spanning chromatography, imaging and cell-therapy tools, will increase at least 10 percent this year, GE said.

“It’s a fundamentally attractive industry with growth and we have a very strong competitive position,’’ Flannery said. “We are certain this business grows faster inside of GE than it would grow outside.”


About Peter Coffaro 1136 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.